American Journal of Neuroradiology 21:881-890 (5 2000)
© 2000 American Society of Neuroradiology
ARTICLE
Dynamic Contrast-enhanced T2*-weighted MR Imaging of Recurrent Malignant Gliomas Treated with Thalidomide and Carboplatin
a From the Departments of Radiology (S.C., E.A.K., G.J., A.L., S.L.), Neurosurgery (E.A.K.), Neuro-oncology (J.G., M.L.G.), and Pathology, Division of Neuropathology (D.Z.); and the Kaplan Cancer Center (E.A.K., M.L.G., D.Z.), New York University Medical Center, New York.
BACKGROUND AND PURPOSE: Dynamic, contrast-enhanced MR imaging has allowed quantitative assessment of cerebral blood volume (CBV) in brain tumors. The purpose of our study was to compare postcontrast T1-weighted imaging with dynamic, contrast-enhanced T2*-weighted echo-planar imaging in the evaluation of the response of recurrent malignant gliomas to thalidomide and carboplatin.
METHODS: Serial MR imaging was performed in 18 consecutive patients with recurrent malignant gliomas receiving both thalidomide and carboplatin for 12-month periods. Six patients undergoing carboplatin therapy alone were chosen as control subjects. Conventional postcontrast T1-weighted images were compared with relative CBV (rCBV) maps calculated on a pixel-by-pixel basis from dynamic echo-planar imaging data. Tumor progression was evaluated clinically using established criteria for malignant gliomas. Studies were performed at 2- to 3-month intervals, and imaging and clinical findings were compared.
RESULTS: Tumor response to treatment, based on clinical findings, did not correlate well with conventional imaging findings. The rCBV values decreased significantly in all patients between the start of therapy and the first follow-up in the study group, but not in the control group. The difference in rCBV values between the clinically stable and the progressive group at 12-month follow-up was statistically significant, with the progressive group having higher values.
CONCLUSION: Dynamic, contrast-enhanced MR imaging is a valuable adjunct to conventional imaging in assessing tumor activity during antiangiogenic therapy, and correlates better than conventional studies with clinical status and response to therapy.
This article has been cited by other articles:
 |
|
 |
|
  M. A. Weber, S. Zoubaa, M. Schlieter, E. Juttler, H. B. Huttner, K. Geletneky, C. Ittrich, M. P. Lichy, A. Kroll, J. Debus, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors Neurology, June 27, 2006; 66(12): 1899 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.L. Boxerman, K.M. Schmainda, and R.M. Weisskoff Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 859 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koeller and E. J. Rushing From the Archives of the AFIP: Oligodendroglioma and Its Variants: Radiologic-Pathologic Correlation RadioGraphics, November 1, 2005; 25(6): 1669 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Cohen, E. A. Knopp, H. Rusinek, J. S. Babb, D. Zagzag, and O. Gonen Assessing Global Invasion of Newly Diagnosed Glial Tumors with Whole-Brain Proton MR Spectroscopy AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2170 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lupo, S. Cha, S. M. Chang, and S. J. Nelson Dynamic Susceptibility-Weighted Perfusion Imaging of High-Grade Gliomas: Characterization of Spatial Heterogeneity AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1446 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Jager, A. D Waldman, C. Benton, N. Fox, and J. Rees Differential Chemosensitivity of Tumor Components in a Malignant Oligodendroglioma: Assessment with Diffusion-Weighted, Perfusion-Weighted, and Serial Volumetric MR Imaging AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 274 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Schmainda, S. D. Rand, A. M. Joseph, R. Lund, B. D. Ward, A. P. Pathak, J. L. Ulmer, M. A. Baddrudoja, and H. G. J. Krouwer Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1524 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Covarrubias, B. R. Rosen, and M. H. Lev Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors Oncologist, September 1, 2004; 9(5): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Hein, C. J. Eskey, J. F. Dunn, and E. B. Hug Diffusion-Weighted Imaging in the Follow-up of Treated High-Grade Gliomas: Tumor Recurrence versus Radiation Injury AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 201 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R Padhani MRI for assessing antivascular cancer treatments Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Wetzel, S. Cha, G. Johnson, P. Lee, M. Law, D. L. Kasow, S. D. Pierce, and X. Xue Relative Cerebral Blood Volume Measurements in Intracranial Mass Lesions: Interobserver and Intraobserver Reproducibility Study Radiology, September 1, 2002; 224(3): 797 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jackson, A. Kassner, D. Annesley-Williams, H. Reid, X.-P. Zhu, and K.-L. Li Abnormalities in the Recirculation Phase of Contrast Agent Bolus Passage in Cerebral Gliomas: Comparison with Relative Blood Volume and Tumor Grade AJNR Am. J. Neuroradiol., January 1, 2002; 23(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cha, S. Pierce, E. A. Knopp, G. Johnson, C. Yang, A. Ton, A. W. Litt, and D. Zagzag Dynamic Contrast-enhanced T2*-weighted MR Imaging of Tumefactive Demyelinating Lesions AJNR Am. J. Neuroradiol., June 1, 2001; 22(6): 1109 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cha, E. A. Knopp, G. Johnson, S. G. Wetzel, A. W. Litt, and D. Zagzag Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging Radiology, April 1, 2002; 223(1): 11 - 29. [Abstract] [Full Text] [PDF]
|
|